供给侧改革背景下中国生物医药产业的发展路径

Research on the Development Paths of Biomedical Industry under the Background of Supply-side Reform in China

基于供给侧改革背景,从生产要素视角出发,分析了中国生物医药产业的发展问题,由此提出了当前中国生物医药产业的改革路径。结果表明,劳动力、资本以及技术要素制约了中国生物医药产业主体的发展。由此提出了构建人才支撑体系、金融支撑体系以及创新支撑体系,通过创新人才培养模式,建立多层次资本市场,提高风险投资的支持,完善针对中小企业的综合金融服务,鼓励原始创新,建立知识产权保护机制,推广产学研合作等措施,促进中国生物医药产业的改革发展。

Under the background of supply-side reform, and from perspective of productive factors, the problems in bio-pharmaceutical industrial development were analyzed, and thus the ways to reform bio-pharmaceutical industry in current China were proposed. The results showed that, the labor force, capital and technology were the key factors limiing the development of bio-pharmaceutical industrial main body. Accordingly, a system based on talent support, capital support and innovation support was proposed, through which well-trained human resources and multi-layer capital market system could be achieved,and thus risk investment support and economic service for minor enterprises could also be reinforced. Finally, measures including encouraging original innovation, enhancing protection on intellectual property and constructing cooperation of industry,education and research were proposed to promote the reform and development of the bio-pharmaceutical industry in China.